Latest News

Repatha lowers low-density lipoprotein cholesterol (LDL-C), a key risk factor for cardiovascular disease, alongside other measures to manage cardiovascular risk.

RushData aims to address these bottlenecks by bringing antibody expression, binding analysis and early developability profiling into a standardised workflow.

Under the agreement, CORE Biomedicine will evaluate and develop the licensed programmes with the aim of creating targeted treatments for a wider range of cancer patients.

Throughout the 42-day period, health authorities maintained enhanced nationwide surveillance and found no evidence of further transmission.

Leishmaniasis is endemic in 80 countries, with an estimated 50,000 to 90,000 new cases reported annually, although WHO estimates that only 25% to 45% of infections are officially documented.

Under the proposed PPP structure, the Egyptian-Turkish consortium will oversee the project’s construction and non-medical operations.

Moscow opened access to its MosMedAI platform to healthcare institutions across Russia in 2024, following a decree by Russian President Vladimir Putin.

The partnership combines Africa CDC’s continental leadership in health security with PSI’s experience in working with governments, communities and partners to design and scale people-centred healthcare solutions.

Dr Sachin Rastogi, consultant anaesthetist, and Akbar Hussain, consultant neurosurgeon and functional neurosurgeon, performed the procedure at the Royal Victoria Infirmary, part of the Newcastle Hospitals group.

The approval makes Simtriyo the first norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) for ADHD and gives Otsuka what Jefferies analysts described as its “next major CNS launch.”